---
title: "Tuoxin Pharmaceutical shareholder Ivos has completed a reduction in holdings, with a total reduction of 2.47% of shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/244718981.md"
description: "According to the Zhitong Finance APP, Tuoxin Pharmaceutical announced that its controlling shareholder and actual controller Yang Xining's concerted actor, Xinxiang Yiwosi Trading Co., Ltd. (referred to as \"Yiwosi\"), has cumulatively reduced its holdings by 3.1221 million shares through centralized bidding and block trading as of June 13, 2025, accounting for 2.47% of the company's total share capital. The reduction period has ended"
datetime: "2025-06-16T12:56:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/244718981.md)
  - [en](https://longbridge.com/en/news/244718981.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/244718981.md)
generator: "portal-rs"
---

# Tuoxin Pharmaceutical shareholder Ivos has completed a reduction in holdings, with a total reduction of 2.47% of shares

According to the Zhitong Finance APP, Tuoxin Pharmaceutical (301089.SZ) announced that its controlling shareholder and actual controller Yang Xining's concerted actor, Xinxiang Yiwosi Trading Co., Ltd. (referred to as "Yiwosi"), has cumulatively reduced its holdings by 3.1221 million shares through centralized bidding and block trading as of June 13, 2025, accounting for 2.47% of the company's total share capital. The reduction period has ended

### Related Stocks

- [301089.CN](https://longbridge.com/en/quote/301089.CN.md)

## Related News & Research

- [Best DIY Mini Splits’ Releases 2025–2026 DIY Ductless Mini Split Rankings](https://longbridge.com/en/news/297805556.md)
- [Top Economist Takes Aim at Kevin Warsh’s Fed: Is Trump’s New Chair an Independent ‘Hawky Hawk’ or a ‘MAGA Sock Puppet’?](https://longbridge.com/en/news/297519761.md)
- [Fanatics extends UC3 trading card partnership for UEFA club competitions through 2033](https://longbridge.com/en/news/297775986.md)
- [Chinese internet giants set to reap AI profits in 2 to 3 years, UBS says](https://longbridge.com/en/news/297738432.md)
- [Xinhua Pharma unit Xincat’s azithromycin tablets pass China generic consistency evaluation](https://longbridge.com/en/news/297485179.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**